Faeth Therapeutics Inc. Company Profile
NASDAQ: FTHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.92-1.97 (-7.33%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Faeth Therapeutics at a glance
Faeth Therapeutics Inc. (NASDAQ: FTH) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Austin, TX. The company's shares have traded publicly since 2021. At a market capitalization of $694.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001829802, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Faeth Therapeutics Inc.
- Ticker
- NASDAQ: FTH
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- 701 Tillery Street #12 #1010 78702, Austin, TX, United States
- Phone
- 512-200-2982
- IPO year
- 2021
- Market cap
- $694.85M
- SEC CIK
- 0001829802
- Latest annual report
- 10-K/A · Jun 2, 2026
Companies similar to Faeth Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OLMAOlema Pharmaceuticals Inc. | 7.94 | +0.25% | $694.73M | vs FTH |
| WVEWave Life Sciences Inc. | 3.54 | +0.57% | $697.55M | vs FTH |
| PHARPharming Group N.V. ADS | 9.65 | -0.31% | $683.01M | vs FTH |
| COLLCollegium Pharmaceutical Inc. | 21.93 | +0.23% | $713.94M | vs FTH |
| NVCTNuvectis Pharma Inc. | 20.29 | +1.30% | $662.35M | vs FTH |
| AVTXAvalo Therapeutics Inc. | 13.58 | -0.07% | $728.30M | vs FTH |
| DSGNDesign Therapeutics Inc. | 11.69 | -2.34% | $731.58M | vs FTH |
| ZVRAZevra Therapeutics Inc. | 11.08 | +3.26% | $657.97M | vs FTH |